Literature DB >> 9589687

Increased oxidizability of low-density lipoproteins in hypothyroidism.

T Diekman1, P N Demacker, J J Kastelein, A F Stalenhoef, W M Wiersinga.   

Abstract

Hypothyroidism leads to an increase of plasma low-density lipoprotein (LDL) cholesterol levels. Oxidation of LDL particles changes their intrinsic properties, thereby enhancing the development of atherosclerosis. T4 has three specific binding sites on apolipoprotein B; furthermore it inhibits LDL oxidation in vitro. We therefore hypothesized that T4 deficiency not only results in elevated LDL-cholesterol levels but also in increased LDL oxidation. Ten patients with overt hypothyroidism were studied when untreated (TSH 76 +/- 13 mU/L, T4 40 +/- 6 nmol/L) and again when they were euthyroid for at least 3 months during T4 treatment (TSH 2.7 +/- 0.5 mU/L, T4 115 +/- 11 nmol/L). Plasma lipids and lipoproteins and the oxidizability and chemical composition of LDL were determined. The transition from the hypothyroid to the euthyroid state was associated with a decrease (mean +/- SE) of plasma total cholesterol (5.8 +/- 0.3 vs. 4.8 +/- 0.2 mmol/L, P < 0.005), LDL cholesterol (3.8 +/- 0.3 vs. 2.9 +/- 0.2 nmol/L, P < 0.005) and apolipoprotein B (1.2 +/- 0.1 vs. 0.9 +/- 0.1 g/L, P < 0.005); plasma high-density lipoprotein cholesterol, apolipoprotein A-1, and triglycerides did not change. The actual content of dienes in LDL particles was increased in hypothyroidism, with a decrease after T4 suppletion [median (range) = 257 (165-346) vs. 188 (138-254) nmol/mg LDL protein, P < 0.005; reference range 140-180]. The lag time, an estimate of the resistance of LDL against oxidation in vitro, was shortened when hypothyroid but normalized after T4 treatment [29 (19-90) vs. 77 (42-96) min, P < 0.005; reference range 67-87]. The density, the relative fatty acid content, and the vitamin E content of LDL particles did not change. In conclusion, the hypothyroid state is not only associated with a quantitative increase of LDL particles, but it also changes their quality by increasing LDL oxidizability.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9589687     DOI: 10.1210/jcem.83.5.4759

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Thyroxine binding to members and non-members of the serine protease inhibitor family.

Authors:  S Benvenga; D Lapa; F Trimarchi
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

2.  Re-evaluation of the thyroxine binding to human plasma lipoproteins using three techniques.

Authors:  S Benvenga; D Lapa; F Trimarchi
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

3.  Assesment of oxidative status and its association with thyroid autoantibodies in patients with euthyroid autoimmune thyroiditis.

Authors:  Husniye Baser; Ummugulsum Can; Salih Baser; Fatma Humeyra Yerlikaya; Uysaler Aslan; Bahauddin Taha Hidayetoglu
Journal:  Endocrine       Date:  2014-08-23       Impact factor: 3.633

Review 4.  Pulmonary hypertension in thyroid diseases.

Authors:  Pietro Scicchitano; Ilaria Dentamaro; Francesco Tunzi; Gabriella Ricci; Santa Carbonara; Fiorella Devito; Annapaola Zito; Anna Ciampolillo; Marco Matteo Ciccone
Journal:  Endocrine       Date:  2016-03-19       Impact factor: 3.633

5.  Is thyroid-stimulating hormone within the normal reference range a risk factor for atherosclerosis in women?

Authors:  Anna Boggio; Fulvio Muzio; Michela Fiscella; Domenico Sommariva; Adriana Branchi
Journal:  Intern Emerg Med       Date:  2011-12-28       Impact factor: 3.397

Review 6.  Hypothyroidism and dyslipidemia: modern concepts and approaches.

Authors:  Elizabeth N Pearce
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

Review 7.  Hypothyroidism as a risk factor for cardiovascular disease.

Authors:  Bernadette Biondi; Irwin Klein
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

8.  Thyroid function and lipid subparticle sizes in patients with short-term hypothyroidism and a population-based cohort.

Authors:  Elizabeth N Pearce; Peter W F Wilson; Qiong Yang; Ramachandran S Vasan; Lewis E Braverman
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

9.  Systemic Thyroid Hormone Status During Levothyroxine Therapy In Hypothyroidism: A Systematic Review and Meta-Analysis.

Authors:  Elizabeth A McAninch; Kumar B Rajan; Corinne H Miller; Antonio C Bianco
Journal:  J Clin Endocrinol Metab       Date:  2018-08-15       Impact factor: 5.958

10.  Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease.

Authors:  Melpomeni Peppa; Grigoria Betsi; George Dimitriadis
Journal:  J Lipids       Date:  2011-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.